InvestmentMay 29, 2026, 04:38 PM
Outlook Therapeutics Sells 8.54M Shares in Direct Offering
AI Summary
Outlook Therapeutics, Inc. completed a registered direct offering of 8,539,709 shares of its common stock. The shares were sold to GMS Ventures and Investments pursuant to a securities purchase agreement entered into on May 28, 2026. This offering was conducted under the company's effective registration statement on Form S-3.
Key Highlights
- Outlook Therapeutics completed a registered direct offering.
- Issued 8,539,709 shares of common stock.
- Shares were sold to GMS Ventures and Investments.
- Offering based on a May 28, 2026 securities purchase agreement.
- Conducted under an effective Form S-3 registration statement.
Price Impact
More from OTLK
USFDA1d ago, 8:03 AM
Outlook Therapeutics FDA Accepts BLA Resubmission; PDUFA July 29, 2026
AGM/EGMJun 1, 5:00 PM
Outlook Therapeutics Special Meeting on July 16 to Vote on Warrant Issuance, Share Increase, and Reverse Split
USFDAJun 1, 8:47 AM
Outlook Therapeutics Resubmits BLA for ONS-5010/LYTENAVA to FDA